Numeric Investors’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Numeric Investors’s Portfolio PGNX Stock Details PGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$351K	Sell	59,000 -234,400	-80%	-$1.42M	﹤0.01%	946
2017 Q3	$2.16M	Sell	293,400 -130,300	-31%	-$828K	0.02%	582
2017 Q2	$2.88M	Buy	+423,700	New	+$3.13M	0.03%	438
2016 Q2	–	Sell	-227,600	Closed	-$992K	–	1232
2016 Q1	$992K	Sell	227,600 -669,570	-75%	-$2.98M	0.01%	561
2015 Q4	$5.5M	Buy	897,170 +290,299	+48%	+$1.9M	0.06%	274
2015 Q3	$3.47M	Buy	606,871 +156,842	+35%	+$1.2M	0.04%	300
2015 Q2	$3.36M	Buy	450,029 +212,429	+89%	+$1.29M	0.04%	314
2015 Q1	$1.42M	Buy	237,600 +211,600	+814%	+$1.33M	0.02%	407
2014 Q4	$197K	Buy	26,000 +2,500	+11%	+$15K	﹤0.01%	789
2014 Q3	$122K	Sell	23,500 -11,500	-33%	-$57.3K	﹤0.01%	772
2014 Q2	$151K	Sell	35,000 -383,485	-92%	-$1.46M	﹤0.01%	730
2014 Q1	$1.71M	Buy	+418,485	New	+$2.14M	0.03%	353

Other funds holding PGNX

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

PFC

Phocas Financial Corp Alameda, California $637M AUM 39.08% 1-Year Est. Return

Numeric Investors's PGNX Position: Q4 2017 in Review

Numeric Investors reduced its Progenics Pharmaceuticals Inc (PGNX) stake by 80% in Q4 2017, selling an estimated $1.42M and leaving 59,000 shares worth $351K. The position accounts for ﹤0.01% of the portfolio, ranked #946.

Numeric Investors first reported a position in PGNX in Q1 2014 and has held it in 12 quarters since. The position peaked at $5.5M in Q4 2015. 153 funds tracked by Wall St. Rank hold PGNX as of Q4 2017.

Numeric Investors held 59,000 shares of Progenics Pharmaceuticals Inc worth $351K as of Q4 2017.
Numeric Investors sold 234,400 Progenics Pharmaceuticals Inc shares in Q4 2017, an estimated $1.42M.
Progenics Pharmaceuticals Inc made up ﹤0.01% of Numeric Investors's portfolio in Q4 2017, its #946 holding.
Numeric Investors first reported a position in Progenics Pharmaceuticals Inc in Q1 2014 and has held it in 12 quarters since.
Numeric Investors's Progenics Pharmaceuticals Inc position peaked at $5.5M in Q4 2015.
153 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.